Please select a community
Automation & Microfluidics
Biologics & Bioprocessing
Chemical Process Scale Up
Food & Beverage Analysis
Forensic Science & Clinical Toxicology
Genotyping & Gene Expression
LIMS & ELNs
Metabolomics & Lipidomics
Molecular & Clinical Diagnostics
Next Gen Sequencing
Stem Cells, Cellular Therapy & Biobanking
Become a Member
Add My Products
OGT Launches Cytocell FISH Probes for Glial Tumours
Saturday, May 07, 2016
Company has announced the launch of its CE-IVD labelled Cytocell Aquarius® 1p36/1q25 and 19q13/19p13 deletion probe kit for the reliable investigation of glial tumours.
Merck Builds on Leading Viral and Gene Therapy Service Offering
Thursday, May 05, 2016
Merck has announced an expansion of its Carlsbad, California facility to meet growing demand for viral and gene therapy products.
DeNovix Showcases Spectrophotometer / Fluorometer System at AACR
Monday, April 18, 2016
Company will present its DS-11 FX+ Spectrophotometer / Fluorometer at this year’s AACR 2016 meeting in New Orleans, LA.
Horizon Introduces New High Throughput Platform
Friday, April 15, 2016
Company has announced that it has launch of a new platform for immuno-oncology research.
New Lung Cancer Test is Now Available in Europe
Thursday, April 07, 2016
Company has announced the commercial availability of new In Vitro Diagnostic test for non-squamous non-small cell lung cancer.
Horizon Discovery Group plc Launches HDx™ RNA Fusion Reference Standards
Wednesday, March 23, 2016
Company has launched HDx™ RNA fusion reference standards optimization and validation of targeted RNA-seq, endpoint RT-PCR or RT-qPCR assays.
Tews Laboratory Uses LaVision BioTec UltraMicroscope
Tuesday, March 22, 2016
Company has announced that the Tews Laboratory uses an UltraMicroscope for research into the molecular mechanisms of tumor invasion and enhanced imaging of cells.
Primary Human Cancer Cells
Wednesday, March 16, 2016
Company has announced that the range of primary human cancer cells obtained directly from a variety tumor types, including breast, colon and prostate.
DNASTAR Releases Lasergene 13 Software to Enhance RNA Research
Thursday, March 03, 2016
Company has announced the release of Lasergene 13 Software to enhance RNA research on model and non-model organisms on standard desktop computers.
Showing Results 11 - 20 of 756
Liquid Biopsies: Miracle Diagnostic or Next New Fad?
Thanks to the development of highly specific gene-amplification and sequencing technologies liquid biopsies access more biomarkers relevant to more cancers than ever before.
Discovered Through ‘Big Data’ Analysis
Researchers at the SBP have identified over 100 new genetic regions that affect the immune response to cancer.
New Therapeutic Targets For Small Cell Lung Cancer Identified
Researchers at UTSW Medical Center have identified a protein termed ASCL1 that is essential to the development of small cell lung cancer and that, when deleted in the lungs of mice, prevents the cancer from forming.
Liquid Biopsies Treating Ovarian Cancer
Researchers have discovered a promising monitor and treat recurrence of ovarian cancer. Detecting cancer long before tumours reappear.
Cell Cargo Ships in Near Future?
Virus-inspired container design may lead to cell cargo ships following construction of ten large, two-component, icosahedral protein complexes.
Uncovering a New Principle in Chemotherapy Resistance in Breast Cancer
The NIH study has revealed an entirely unexpected process for acquiring drug resistance that bypasses the need to re-establish DNA damage repair in breast cancers that have mutant BRCA1 or BRCA2 genes.
Understanding Treatment Resistant Melanoma
Researchers have determined how advanced melanoma becomes resistant; a development toward developing treatments.
Liquid Biopsies: DNA Size Matters
Study finds circulating tumour DNA can be distinguished from healthy DNA through fragment size identification.
Unravelling the Roots of Insect’s Waterproof Coating
Researchers have identified the genes that control cuticular lipid production in Drosophila, by performing an RNAi screen and using Direct Analysis in Real Time and GC-MS.
Identifying Cancer Drug Targets Using 3D-Modelling
Researchers are now able to model genetic mutations manipulation of proteins that can potentially drive cancer.
Advertise On This Site
Terms & Conditions
©2016 Technology Networks
, all rights reserved.
Latest presentations and webinars
3,200+ scientific and medical posters
4,800+ scientific videos
JOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!